Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 401–500 of 999

Pediatric reference intervals for lipids and apolipoproteins on the VITROS 5,1 FS Chemistry System
Yip, P. S. F., Chan, M. K., Nelken, J., Lepage, N., Brotea, G., & Adeli, K. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.06.012 · Cited by 46
Experimental Models for the Investigation of High-Density Lipoprotein–Mediated Cholesterol Efflux
Santos‐Gallego, C. G., Giannarelli, C., & Badimón, J. J. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0177-0 · Cited by 49
Myocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus Gerbils
Sahraoui, A., Dewachter, C., de Medina, G., Naeije, R., Bouguerra, S. A., & Dewachter, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148117 · Cited by 46
Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients
Lemieux, I., Houde, I., Pascot, A., Lachance, J.-G., Noël, R., Radeau, T., Després, J., & Bergeron, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00611.x · Cited by 46
Usefulness of total cholesterol/HDL‐cholesterol ratio in the management of diabetic dyslipidaemia
Gimeno-Orna, J. A., Faure-Nogueras, E., & Sancho‐Serrano, M. A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01341.x · Cited by 46
The New National Cholesterol Education Program Guidelines
Eidelman, R. S., Lamas, G. A., & Hennekens, C. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2033 · Cited by 46
Self-citation
Session 4: Challenges facing the food industry in innovating for health Impact on CVD risk of modifying milk fat to decrease intake of SFA and increase intake of cis-MUFA
Givens, D. I. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108008707 · Cited by 47
Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology
Kulkarni, K. R., Marcovina, S. M., Krauss, R. M., Garber, D. W., Glasscock, A. M., & Segrest, J. P. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34949-x · Cited by 45
Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women
Malpuech‐Brugère, C., Mouriot, J., Vaysse, C., Combe, N., Peyraud, J.-L., Leruyet, P., Chesneau, G., Morio, B., & Chardigny, J. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.73 · Cited by 46
Stroke risk factors and subtypes in different age groups: A hospital-based study
Wu, C.-Y., Wu, C., Lee, J.-D., & Weng, H. (2010) · Neurology India · doi:10.4103/0028-3886.73747 · Cited by 46
The lipoprotein subfraction profile: heritability and identification of quantitative trait loci
Kaess, B. M., Fischer, M., Baessler, A., Stark, K. J., Huber, F., Kremer, W., Kalbitzer, H. R., Schunkert, H., Riegger, G. A. J., & Hengstenberg, C. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700338-jlr200 · Cited by 44
Technological stress: psychophysiological aspects of working with modern information technology.
Arnetz, B. B. (1997) · PubMed · Cited by 45
Exercise Training for Claudicants: Changes in Blood Flow, Cardiorespiratory Status, Metabolic Functions, Blood Rheology and Lipid Profile
Tan, K. H., Cotterrell, D., Sykes, K., Sissons, G. R. J., de Cossart, L., & Edwards, P. R. (2000) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2000.1137 · Cited by 45
Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation
Zambón, D., Ros, E., Rodrı́guez-Villar, C., Laguna, J. C., Vázquez, M., Sanllehy, C., Casals, E., Sol, J. M., & Hernández, G. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90009-4 · Cited by 45
Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile
Donner, M. G., Klein, G., Mathes, P., SCHWANDT, P., & Richter, W. O. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90256-6 · Cited by 44
A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease
Takata, K., Saku, K., Ohta, T., Takata, M., Bai, H., Jimi, S., Liu, R., Sato, H., Kajiyama, G., & Arakawa, K. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1866 · Cited by 45
Effects of tibolone on lipoprotein(a) and HDL subfractions
FARISH, E., Barnes, J. F., Rolton, H. A., Spowart, K., Fletcher, C. D., & Hart, D. M. (1994) · Maturitas · doi:10.1016/0378-5122(94)90019-1 · Cited by 45
Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse
Spady, D. K., Woollett, L. A., Meidell, R. S., & Hobbs, H. H. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32530-x · Cited by 45
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel
Janaud, A., Rouffy, J., Upmalis, D. H., & Dain, M. (1992) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349209156513 · Cited by 45
Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL3 cholesterol
Sillanaukee, P., Koivula, T. A., Jokela, H., Pitkäjärvi, T., & Seppä, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00369-5 · Cited by 43
Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias
Sniderman, A. D., & Cianflone, K. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.4.489 · Cited by 45
Blood lipid concentrations and risk of myocardial infarction
Médiène-Benchekor, S., Brousseau, T., Richard, F., Benhamamouch, S., & Amouyel, P. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06200-6 · Cited by 44
Biomarkers of Coronary Artery Disease Differ Between Asians and Caucasians in the General Population
Gijsberts, C. M., den Ruijter, H. M., Asselbergs, F. W., Chan, M. Y., de Kleijn, D. P. V., & Hoefer, I. E. (2015) · Global Heart · doi:10.1016/j.gheart.2014.11.004 · Cited by 45
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol
Bersot, T. P., Pépin, G. M., & Mahley, R. W. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00516-7 · Cited by 45
High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
Arts, E., Fransen, J., Lemmers, H., Stalenhoef, A. F. H., Joosten, L. A. B., van Riel, P. L. C. M., & Popa, C. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3842 · Cited by 44
Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL‐cholesterol levels: a 12‐week randomized trial
Després, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 44
Meta-Analysis of Apolipoprotein E Gene Polymorphism and Susceptibility of Myocardial Infarction
Xu, H. W., Li, H., Liu, J., Zhu, D., Wang, Z., Chen, A., & Zhao, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104608 · Cited by 43
Plasma lipoproteins, apoproteins and cardiovascular disease in Type 2 diabetic patients. A nine-year follow-up study
della Rovere, G. R., Lapolla, A., Sartore, G., Rossetti, C., Zambon, S., Minicuci, N., Crepaldi, G., Fedele, D., & Manzato, E. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80167-9 · Cited by 43
High Density Lipoproteins Stimulate Mitogen-Activated Protein Kinases in Human Skin Fibroblasts
Deeg, M. A., Bowen, R. F., Oram, J. F., & Bierman, E. L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1667 · Cited by 43
Population Frequency Distributions of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B in Healthy Men and Women and Associations with Age, Gender, Hormonal Status, and Sex Hormone Use: The Stanford Five City Project
Gardner, C. D., Tribble, D. L., Young, D. R., Ahn, D. K., & Fortmann, S. P. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0715 · Cited by 43
Intramuscular Testosterone Enanthate Plus Very Low Dosage Oral Levonorgestrel Suppresses Spermatogenesis Without Causing Weight Gain in Normal Young Men: A Randomized Clinical Trial
Anawalt, B. D., Amory, J. K., Herbst, K. L., Coviello, A. D., Page, S. T., Bremner, W. J., & Matsumoto, A. M. (2005) · Journal of Andrology · doi:10.2164/jandrol.04135 · Cited by 43
The effect of serum lipids and oxidized low-density lipoprotein of supplementing self-selected low-fat diets with soluble-fiber, soy, and vegetable protein foods
Jenkins, D. J. A., Kendall, C. W. C., Vidgen, E., Mehling, C. C., Parker, T. L., Seyler, H., Faulkner, D. A., Garsetti, M., Griffin, L. C., Agarwal, S., et al. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90738-8 · Cited by 41
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial
Asztalos, B. F., Demissie, S., Cupples, L. A., Collins, D. E., Cox, C. E., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.018 · Cited by 42
A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease
Ikewaki, K., Matsunaga, A., Han, H., Watanabe, H., Endo, A., Tohyama, J., Kuno, M., Mogi, J., Sugimoto, K., Tada, N., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.024 · Cited by 42
Risk variables for coronary artery disease in Asian Indians
Ramachandran, A., Sathyamurthy, I., Snehalatha, C., Kumpatla, S., Sivasankari, S., Misra, J., Girinath, M. R., & Viswanathan, V. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01356-4 · Cited by 42
Prevalencia de colesterol LDL inadecuado en pacientes con enfermedad coronaria y/o diabetes mellitus tipo 2
de Isla, L. P., Cerezo, A. S., Vitale, G. C., González-Timón, B., do Rego, A. T., & Álvarez-Sala, J. L. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.07.003 · Cited by 41
Food consumption and the actual statistics of cardiovascular diseases: an epidemiological comparison of 42 European countries
Grasgruber, P., Sebera, M., Hrazdíra, E., Hřebíčková, S., & Cacek, J. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.31694 · Cited by 41
The C‐480T hepatic lipase polymorphism is associated with HDL‐C but not with risk of coronary heart disease
McCaskie, P. A., Cadby, G., Hung, J., McQuillan, B., Chapman, C., Carter, K. W., Pl, T., Palmer, L. J., & Beilby, J. P. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00659.x · Cited by 39
Fatty Acids and Atherosclerotic Risk
Thijssen, M. A. M. A., & Mensink, R. P. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_5 · Cited by 41
Dietary and serum lipids in individuals with spinal cord injury living in the community.
Moussavi, R. M., Ribas-Cardús, F., Rintala, D. H., & Rodriguez, G. P. (2001) · PubMed · Cited by 41
HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism
Schiavon, R., Battaglia, P., Fanti, E. D., Fasolin, A., Biasioli, S., Targa, L., & Guidi, G. C. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00216-4 · Cited by 41
A rationale for plasma cholesterol modulation by dietary fatty acids: Modeling the human response in animals
Hayes, K. C., Prończuk, A., & Khosla, P. (1995) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(95)00034-w · Cited by 41
Impact of polystyrene microplastic exposure on lipid profile and oxidative stress status of male and female Wistar rats
Nnoruka, U. C., Okonkwo, C. J., Ilechukwu, I., Okonkwo, C. J., & Belonwu, D. C. (2022) · Environmental Analysis Health and Toxicology · doi:10.5620/eaht.2022024 · Cited by 41
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
Gitt, A. K., Jünger, C., Smolka, W., & Bestehorn, K. P. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0177-z · Cited by 40
Association of serum lipoprotein ratios with insulin resistance in type 2 diabetes mellitus.
Tangvarasittichai, S., Poonsub, P., & Tangvarasittichai, O. (2010) · PubMed · Cited by 40
Kualitas Minyak Goreng dan Produk Gorengan selama Penggorengan di Rumah Tangga Indonesia
Ilmi, I. M. B. (2015) · Jurnal Aplikasi Teknologi Pangan · doi:10.17728/jatp.2015.12 · Cited by 42
Obesidade na adolescência: fator de risco para complicações clínico-metabólicas
Carneiro, J. R. I., Kuschnir, M. C. C., Clemente, E. L. S., Brandão, M. G., & Gomes, M. B. (2000) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302000000500005 · Cited by 34
Effects of apolipoprotein A‐I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels
Larson, I., Ordovás, J. M., Barnard, J., Hoffmann, M., Feussner, G., Lamon‐Fava, S., & Schaefer, E. J. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.610302.x · Cited by 40
Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins
Brown, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00293-4 · Cited by 41
Medical Consequences of Alcohol Consumption—United States, 1992
Chou, S. P., Grant, B. F., & Dawson, D. A. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01144.x · Cited by 38
Relationship of alcohol consumption to changes in HDL‐subfractions
Sillanaukee, P., Koivula, T., Jokela, H., Myllyharju, H., & Seppä, K. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00795.x · Cited by 38
The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial
Nolte, W., Rädisch, C., Armstrong, V. W., Hüfner, M., & Mühlen, A. V. Z. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370459 · Cited by 40
Lipids in health and disease
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families
Alagona, C., Soro, A., Ylitalo, K., Salonen, R. M., Salonen, J. T., & Taskinen, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00243-5 · Cited by 39
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis
Romano, S., Salustri, E., Ruscitti, P., Carubbi, F., Penco, M., & Giacomelli, R. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0790-9 · Cited by 39
Changes in lipids associated with change in regular exercise in free-living men
Wei, M., Macera, C. A., Hornung, C. A., & Blair, S. N. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00150-9 · Cited by 39
Effects of lipids and lipid‐lowering therapy on hemostatic factors in patients with myocardial infarction
Kaba, N. K., Francis, C. W., Moss, A. J., Zaręba, W., Oakes, D., Knox, K. L., Fernandez, I. D., & Rainwater, D. L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00658.x · Cited by 39
Polymorphism inAPOBAssociated with Increased Low-Density Lipoprotein Levels in Both Genders in the General Population
Benn, M., Nordestgaard, B. G., Jensen, J. S., Grande, P., Sillesen, H. H., & Tybjærg‐Hansen, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0974 · Cited by 39
Cloning and Expression of a Novel Lysophospholipase Which Structurally Resembles Lecithin Cholesterol Acyltransferase
Taniyama, Y., Shibata, S., Kita, S., Horikoshi, K., Fuse, H., Shirafuji, H., Sumino, Y., & Fujino, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0411 · Cited by 39
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
Leroux, G., Lemieux, I., Lamarche, B., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90688-7 · Cited by 39
Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs
Rubinstein, A., Elorriaga, N., Garay, O. U., Poggio, R., Caporale, J., Matta, M. G., Augustovski, F., Pichón-Rivière, A., & Mozaffarian, D. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.150516 · Cited by 40
Safety, Tolerance, and Efficacy of Extended-Release Niacin Monotherapy for Treating Dyslipidemia Risks in Persons With Chronic Tetraplegia: A Randomized Multicenter Controlled Trial
Nash, M. S., Lewis, J. E., Dyson‐Hudson, T. A., Szlachcic, Y., Yee, F., Mendez, A. J., Spungen, A. M., & Bauman, W. A. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2010.06.029 · Cited by 38
Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells
Ohta, T., Saku, K., Takata, K., Nakamura, R., Ikeda, Y., & Matsuda, I. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.956 · Cited by 38
Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: The role of interdisciplinary therapy
Sanches, P. D. L., de Piano, A., Campos, R. M. D. S., Carnier, J., de Mello, M. T., Elías, N., Fonseca, F. A. H., Masquio, D. C. L., da Silva, P. L., Corgosinho, F. C., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.02.007 · Cited by 37
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Factor analysis of possible risks for hypertension in a black South African population
Schutte, A. E., van Rooyen, J. M., Huisman, H. W., Kruger, H. S., & de Ridder, J. H. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001553 · Cited by 37
Beyond Saturated Fat: The Importance of the Dietary Fatty Acid Profile on Cardiovascular Disease
Griel, A. E., & Kris‐Etherton, P. M. (2006) · Nutrition Reviews · doi:10.1301/nr.2006.may.257-262 · Cited by 36
Factors influencing the relation between alcohol and cardiovascular disease
Grønbæk, M. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000203889.50138.98 · Cited by 36
The Effect of High Density Lipoprotein Subfractions on Endothelial Eicosanoid Secretion
Oravec, S., Demuth, K., Myara, I., & Hornych, A. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00106-6 · Cited by 37
MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, S., & Laakso, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.791 · Cited by 37
Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations
Asztalos, B. F., LeFevre, M. L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Wong, L., & Roheim, P. S. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1885 · Cited by 37
Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis
García‐González, V., Delgado‐Coello, B., Pérez‐Torres, A., & Mas‐Oliva, J. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.004 · Cited by 36
Predictive value of different HDL particles for the protection against or risk of coronary heart disease
Rye, K., & Barter, P. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.012 · Cited by 36
Prevalence and Characteristics of Lipid Abnormalities in Patients Treated With Statins in Primary and Secondary Prevention in Spain. DYSIS-Spain Study
González‐Juanatey, J. R., Millán, J., Alegría, E., Guijarro, C., Lozano, J. V., & Vitale, G. C. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.10.030 · Cited by 35
Lauric Acid, a Dietary Saturated Medium-Chain Fatty Acid, Elicits Calcium-Dependent Eryptosis
Alfhili, M. A., & Aljuraiban, G. S. (2021) · Cells · doi:10.3390/cells10123388 · Cited by 36
Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
Abe, H., Tsuboi, N., Suzuki, S., Sakuraba, H., Takanashi, H., Tahara, K., Tonozuka, N., Hayashi, T., & Umeda, M. (2001) · PubMed · Cited by 36
Pediatric Coronary Allograft Vasculopathy-A Review of Pathogenesis and Risk Factors
Schumacher, K. R., Gajarski, R. J., & Urschel, S. (2011) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2011.00601.x · Cited by 36
Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol
Kawano, Y., Tamura, A., & Kadota, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.004 · Cited by 38
Associations of HDL, HDL2, and HDL3 Cholesterol and Apolipoproteins A-I and B with Lifestyle Factors in Healthy Women and Men: The Stanford Five City Project
Gardner, C. D., Tribble, D. L., Young, D. R., Ahn, D. K., & Fortmann, S. P. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0716 · Cited by 35
Targeted Replacement of Mouse Apolipoprotein A-I with Human ApoA-I or the Mutant ApoA-IMilano
Parolini, C., Chiesa, G., Zhu, Y., Forte, T. M., Caligari, S., Gianazza, E., Sacco, M. G., Sirtori, C. R., & Rubin, E. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207335200 · Cited by 36
Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach
Shah, P. K. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780487520 · Cited by 35
Hypertriglyceridemia: Risks and perspectives
Gotto, A. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91086-j · Cited by 37
Factors influencing the relation between alcohol and mortality - with focus on wine
Grønbæk, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00885.x · Cited by 39
Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins
O'Brien, B. C., & Andrews, V. G. (1993) · Lipids · doi:10.1007/bf02536352 · Cited by 36
A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men
Liu, S., Ma, J., Ridker, P. M., Breslow, J. L., & Stampfer, M. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00335-0 · Cited by 35
Self-citation
Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians
van der Steeg, W. A., Hovingh, G. K., Klerkx, A. H. E. M., Hutten, B. A., Nootenboom, I. C., Levels, J. H. M., van Tol, A., Dallinga‐Thie, G. M., Zwinderman, A. H., Kastelein, J. J. P., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600405-jlr200 · Cited by 36
Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus
Ikewaki, K., Mochizuki, K., Iwasaki, M., Nishide, R., Mochizuki, S., & Tada, N. (2002) · Metabolism · doi:10.1053/meta.2002.35191 · Cited by 36
Comparison of a New Method for the Direct and Simultaneous Assessment of LDL- and HDL-Cholesterol with Ultracentrifugation and Established Methods
Benlian, P., Cansier, C., Hennache, G., Khallouf, O., Bayer, P., Duron, F., Carrat, F., Couderc, R., Chazouillères, O., Bardet, J., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.4.493 · Cited by 35
Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies.
Karnoutsos, K., Papastergiou, P., Stefanidis, S., & Vakaloudi, A. (2008) · PubMed Central · Cited by 35
Drug control of reverse cholesterol transport
Franceschini, G., Werba, J. P., & Calabresi, L. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90014-0 · Cited by 35
High-density lipoprotein subfractions as markers of early atherosclerosis
Atger, V., Giral, P., Simon, A. C., Cambillau, M., Levenson, J. A., Gariépy, J., Mégnien, J. L., & MOATTI, N. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)80060-0 · Cited by 35
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events
Sing, K., Ballantyne, C. M., Ferlic, L. L., Brugada, R., Cushman, I., Dunn, J. K., Herd, J. A., Pownall, H. J., Gotto, A. M., & Marian, A. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00004-0 · Cited by 35
Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention
Ascaso, J. F., ndez-Cruz, A. F., Santos, P. G. L., Hernández‐Mijares, A., Mangas, A., n, J. M., Pallardo, L. F., Pedro‐Botet, J., Pérez‐Jiménez, F., a, G. P., et al. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00003 · Cited by 36
Severe Familial HDL Deficiency in French-Canadian Kindreds
Marcil, M., Boucher, B., Krimbou, L., Solymoss, B., Davignon, J., Frohlich, J. J., & Genest, J. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1015 · Cited by 35
Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels
Richard, F., Marécaux, N., Dallongeville, J., Devienne, M., Tiem, N., Fruchart, J., Fantino, M., Zylberberg, G., & Amouyel, P. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90018-4 · Cited by 34
Association betweentrans-fatty acids in erythrocytes and pro-atherogenic lipid profiles among Canadian Inuit of Nunavik: possible influences of sex and age
Counil, É., Julien, P., Lamarche, B., Château‐Degat, M., Ferland, A., & Dewailly, É. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509297182 · Cited by 34
Nanostructured NiO-based reagentless biosensor for total cholesterol and low density lipoprotein detection
Kaur, G., Tomar, M., & Gupta, V. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0147-z · Cited by 34
Differences in the Phenotype Between Children With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Pimstone, S. N., Defesche, J. C., Clee, S. M., Bakker, H. D., Hayden, M. R., & Kastelein, J. J. P. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.5.826 · Cited by 34
Blood lipids in Greek adolescents and their relation to diet, obesity, and socioeconomic factors.
Petridou, E., Malamou, H., Doxiadis, S., Pantelakis, S., Kanellopoulou, G., Toupadaki, N., Trichopoulou, A., Flytzani, V., & Trichopoulos, D. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00094-a · Cited by 42
Designer laying hen diets to improve egg fatty acid profile and maintain sensory quality
Goldberg, E. M., Ryland, D., Gibson, R. A., Aliani, M., & House, J. D. (2013) · Food Science & Nutrition · doi:10.1002/fsn3.47 · Cited by 32

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks